"Livedo reticularis"

Sarcoidosis with the livedo reticularis-like appearance. Sarcoidosis is a multisystem inflammatory disease manifesting as noncaseating epithelioid cell granulomas. 25 to 30% of individuals with systemic sarcoidosis show variable cutaneous manifestations. A 59-year-old female was seen with reticular purplish-red nodules and plaques on the legs for three months. A skin biopsy of the livedo area revealed non-caseating epithelioid cell granulomas surrounding blood vessels in the dermis. She was diagnosed with sarcoidosis livedo, and cutaneous lesions subsided with oral prednisone. Sarcoidosis livedo (SL) assumes a uncommon livedo reticularis-like presentation. This is the first Chinese patient with SL, and more patients are needed to unveil the unique characters of SL.

Livedo reticularis after COVID-19 vaccination. An 80-year-old woman presented with eruption. She had received the third dose of COVID-19 vaccine (Pfizer-BioNTech9®) 40 days prior to presentation and had high fever and pain at the injection site for a week. The day following vaccination, livedo reticularis was observed at the injection site on her left upper arm and its periphery with intense

Livedo reticularis: a cutaneous clue to an underlying endocrine crisis A 54-year-old woman was admitted to hospital with a presumed allergic reaction to a single dose of amoxicillin given for a suspected upper respiratory tract infection. She complained of chest tightness although there was no wheeze or stridor. On examination, she was pyrexial, tachycardic, hypertensive and had a diffuse mottled

Livedo Reticularis on the Lower Limbs in a Patient with Lupus Erythematosus: A Quiz. is missing (Quiz).

Chemical lumbar sympathectomy in the treatment of idiopathic livedo reticularis. Livedo reticularis (LR) is a reticulated discoloration of the skin, particularly on lower extremities. Few treatment options are reported. This study investigated the efficacy and safety of chemical lumbar sympathectomy (CLS) in idiopathic LR. The key technique points of CLS are also illustrated in detail. Patients

Post-partum pituitary insufficiency and livedo reticularis presenting a diagnostic challenge in a resource limited setting in Tanzania: a case report, clinical discussion and brief review of existing literature. Pituitary disorders following pregnancy are an important yet under reported clinical entity in the developing world. Conversely, post partum panhypopituitarism has a more devastating autoimmune condition. These included a history of post-partum thyroiditis, alopecia areata, livedo reticularis and deranged coagulation indices. A remarkable clinical response followed appropriate hormone replacement therapy including steroids. This constellation has never been reported before; we therefore present an interesting clinical discussion including a brief review of existing literature. Post

Livedo Reticularis in a Patient With Pheochromocytoma Resolving After Adrenalectomy.

-associated morbidity Full detailsOther diagnostic factors * history of systemic lupus erythematosus * features of thrombocytopenia * arthralgia/arthritis * livedo reticularis * history of other rheumatological disorders or connective tissue disorders * cardiac murmur * oedema * seizure, headache, memory loss, signs of transverse myelopathy * limb discomfort, swelling, skin discoloration, and ulcers Full

, resulting in an increase in number and size of circulating platelets. History and examKey diagnostic factors * erythromelalgia * splenomegaly * arterial and venous thrombosis * bleeding * livedo reticularis Full detailsOther diagnostic factors * age ≥60 years * female sex * headache * dizziness, lightheadedness, chest pain, vertigo, and paraesthesia * syncope and seizures * transient visual disturbances

, anosmia, ageusia, rhabdomyolysis, peripheral neuropathy, gastrointestinal symptoms, de novo or acute worsening of chronic hyperglycemia, ocular symptoms, encephalopathy, skin changes, and livedo reticularis.3.5. Symptoms and SignsAppendix 6 outlines and defines common cardiovascular and noncardiovascular symptoms in patients with COVID-19, as well as an abbreviated list of physical examination findings

of autoantibodies against proteins bound to cell membrane phospholipids. It is associated with thrombosis (venous, arterial, or microvascular) and/or pregnancy complications such as recurrent miscarriage, late pregnancy loss, or pre-eclampsia. There may be accompanying features such as thrombocytopenia, livedo reticularis, renal disease and neurologic symptoms. APS may occur in the setting of underlying should receive aggressive thromboprophylaxis in high-risk situations. APS may be associated with a number of other © 2020 Thrombosis Canada Page 4 of 5 manifestations such as immune thrombocytopenia and livedo reticularis; there is no evidence to support treatment with anticoagulants for those conditions alone. Pregnant women with antiphospholipid antibodies: It is recommended that pregnant women who

, but these are rarely an issue on ICU. ●Failure of enteral nutrition is likely due more to the use of drugs (such as opioids) and this factor - together with possible intra-abdominal pathology - should be considered. Skin ●Skin involvement is commonplace and manifests most commonly as a maculopapular rash or urticaria. ●Chilblains (‘Covid Toe’) and vesicular lesions are also seen, with livedo reticularis seen less

(fetal growth restriction), stillbirth systemic lupus erythematosus: testing for LA is part of the diagnostic criteria and contributes to risk assessment LA testing could be considered in the following situations: immune thrombocytopenia, particularly with presence of arthralgias or arthritis, hair loss, sun sensitivity, mouth ulcers, rash, thromboembolism livedo reticularis, particularly with presence